A detailed history of Sittner & Nelson, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Sittner & Nelson, LLC holds 6,091 shares of ILMN stock, worth $823,564. This represents 0.36% of its overall portfolio holdings.

Number of Shares
6,091
Previous 6,091 -0.0%
Holding current value
$823,564
Previous $635,000 25.04%
% of portfolio
0.36%
Previous 0.32%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$101.05 - $133.57 $20,210 - $26,714
-200 Reduced 3.18%
6,091 $635,000
Q1 2024

May 10, 2024

SELL
$127.73 - $147.2 $12,773 - $14,719
-100 Reduced 1.56%
6,291 $863,000
Q4 2023

Feb 12, 2024

SELL
$92.79 - $142.53 $95,573 - $146,805
-1,030 Reduced 13.88%
6,391 $889,000
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $29,004 - $43,299
-225 Reduced 2.94%
7,421 $1.02 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $43,106 - $54,677
-235 Reduced 2.98%
7,646 $1.43 Million
Q1 2023

May 09, 2023

SELL
$193.75 - $232.55 $38,750 - $46,510
-200 Reduced 2.47%
7,881 $1.83 Million
Q4 2022

Feb 01, 2023

BUY
$187.24 - $242.74 $14,043 - $18,205
75 Added 0.94%
8,081 $1.63 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $148,873 - $191,049
840 Added 11.72%
8,006 $1.53 Million
Q2 2022

Aug 12, 2022

BUY
$181.58 - $368.0 $43,579 - $88,320
240 Added 3.47%
7,166 $1.32 Million
Q1 2022

May 10, 2022

BUY
$303.87 - $423.8 $113,951 - $158,925
375 Added 5.72%
6,926 $2.42 Million
Q4 2021

Feb 09, 2022

BUY
$347.28 - $421.83 $24,309 - $29,528
70 Added 1.08%
6,551 $2.49 Million
Q1 2021

May 06, 2021

SELL
$361.28 - $504.76 $8,670 - $12,114
-24 Reduced 0.37%
6,481 $2.49 Million
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $1.9 Million - $2.41 Million
6,505 New
6,505 $2.41 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Sittner & Nelson, LLC Portfolio

Follow Sittner & Nelson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sittner & Nelson, LLC with notifications on news.